Skip to main content

Table 1 The clinicopathological information of 40 RCC patients

From: Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

Sample ID Gender Age Subtype Tumor grade TNM stage AJCC stagea OS (months) DFS (months) Outcome
1 Male 76 ccRCC G2 T3aN0M0 III 34 34 Death
2 Male 74 ccRCC G2 T1aN0M0 I 32 32 Death
3 Male 31 ccRCC G3 T3aN0M0 III 63 63 Death
4 Male 74 ccRCC G2 T1aN0M0 I 62 62 Death
5 Male 54 ccRCC G2 T1aN0M0 I 57 57 Death
6 Male 62 ccRCC G2 T1aN0M0 I 76 64 Survival (metastasis)
7 Female 40 ccRCC G3 T3bN0M0 III 74 24 Survival (metastasis)
8 Female 57 ccRCC G2 T1aN0M0 I 74 24 Survival (metastasis)
9 Male 56 ccRCC G2 T3aN0M0 III 72 9 Survival (metastasis)
10 Male 59 ccRCC G3 T1bN0M0 I 71 12 Survival (metastasis)
11 Male 55 ccRCC G1 T1bN0M0 I 74 74 Survival
12 Male 62 ccRCC G2 T1bN0M0 I 74 74 Survival
13 Male 54 ccRCC G2 T1aN0M0 I 74 74 Survival
14 Male 60 ccRCC G2 T1bN0M0 I 74 74 Survival
15 Male 48 ccRCC G1 T1aN0M0 I 74 74 Survival
16 Male 68 ccRCC G2 T1bN0M0 I 73 73 Survival
17 Male 48 ccRCC G2 T1aN0M0 I 73 73 Survival
18 Male 73 ccRCC G1 T1aN0M0 I 73 73 Survival
19 Female 58 ccRCC G2 T1aN0M0 I 72 72 Survival
20 Male 48 ccRCC G2 T1aN0M0 I 72 72 Survival
21 Male 49 PRCC G2 T2N0M0 II 15 15 Death
22 Female 66 PRCC G2 T3aN1M0 III 37 37 Death
23 Male 70 PRCC G2 T3aN0M0 III 66 66 Death
24 Male 63 PRCC G2 T3bN0M0 III 29 29 Death
25 Male 65 PRCC G2 T1aN0M0 I 49 49 Death
26 Female 22 PRCC G1 T1aN0M0 I 76 76 Survival
27 Female 60 PRCC G2 T1aN0M0 I 74 74 Survival
28 Male 69 PRCC G2 T1aN0M0 I 73 73 Survival
29 Male 59 PRCC G2 T1aN0M0 I 71 71 Survival
30 Male 58 PRCC G2 T1aN0M0 I 69 69 Survival
31 Female 49 ChRCC NA T2N0M0 II 86 86 Survival
32 Male 64 ChRCC NA T1aN0M0 I 85 85 Survival
33 Female 37 ChRCC NA T1aN0M0 I 85 85 Survival
34 Male 36 ChRCC NA T1bN0M0 I 84 84 Survival
35 Female 54 ChRCC NA T1aN0M0 I 84 84 Survival
36 Female 52 ChRCC NA T1aN0M0 I 82 82 Survival
37 Female 75 ChRCC NA T1aN0M0 I 78 78 Survival
38 Male 40 ChRCC NA T1bN0M0 I 77 77 Survival
39 Female 36 ChRCC NA T1bN0M0 I 77 77 Survival
40 Female 49 ChRCC NA T1bN0M0 I 76 76 Survival
  1. RCC renal cell carcinoma, TNM tumor-node metastasis stage, AJCC American Joint Committee on Cancer, OS overall survival, DFS disease-free survival, ccRCC clear cell renal cell carcinoma, PRCC papillary renal cell carcinoma, ChRCC chromophobe renal cell carcinoma, NA not available
  2. aThe 7th edition of the AJCC Cancer Staging Manual was used